Aquaporin-4 Knockout Exacerbates Corticosterone-Induced Depression by Inhibiting Astrocyte Function and Hippocampal Neurogenesis

CNS Neuroscience and Therapeutics

Volumn 20, Issue 5, 2014, Pages 391-402

  Kong, Hui ^a,b   Zeng, Xiao Ning ^a,b   Fan, Yi ^b   Yuan, Song Tao ^b   Ge, Song ^a   Xie, Wei Ping ^a   Wang, Hong ^a   Hu, Gang ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Aquaporin 4; Astrocyte function; Depression; Neurogenesis

Indexed keywords

AQUAPORIN 4; CORTICOSTERONE; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; SYNAPSIN I; AQP4 PROTEIN, MOUSE; GDNF PROTEIN, MOUSE; SLC1A2 PROTEIN, MOUSE; SYNAPSIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CELL FUNCTION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED SWIM TEST; GENE INACTIVATION; GENOTYPE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEURAL STEM CELL; NEWBORN; NONHUMAN; TAIL SUSPENSION TEST; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL DEATH; DISEASE MODEL; GENETICS; INBRED MOUSE STRAIN; KNOCKOUT MOUSE; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AQUAPORIN 4; ASTROCYTES; CELL DEATH; CELLS, CULTURED; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; MALE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NEUROGENESIS; SYNAPSINS;

EID: 84899115028     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12222     Document Type: Article

References (59)

1. Zunszain PA, Anacker C, Cattaneo A, et al. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:722-729.
2. Duman RS, Aghajanian GK. Synaptic dysfunction in depression: Potential therapeutic targets. Science 2012;338:68-72.
3. Rajkowska G, Stockmeier CA. Astrocyte pathology in major depressive disorder: Insights from human postmortem brain tissue. Curr Drug Targets 2013;14:1225-1236.
4. Banasr M, Duman RS. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 2008;64:863-870.
5. Iwata M, Shirayama Y, Ishida H, et al. Hippocampal astrocytes are necessary for antidepressant treatment of learned helplessness rats. Hippocampus 2011;21:877-884.
6. Sanacora G, Banasr M. From pathophysiology to novel antidepressant drugs: Glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry 2013;73:1172-1179.
7. Kittel-Schneider S, Kenis G, Schek J, et al. Expression of monoamine transporters, nitric oxide synthase 3, and neurotrophin genes in antidepressant-stimulated astrocytes. Front Psychiatry 2012;3:33.
8. Hundal O. Major depressive disorder viewed as a dysfunction in astroglial bioenergetics. Med Hypotheses 2007;68:370-377.
9. Cao X, Li LP, Wang Q, et al. Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med 2013;19:773-777.
10. Ashton RS, Conway A, Pangarkar C, et al. Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling. Nat Neurosci 2012;15:1399-1406.
11. Kong H, Fan Y, Xie J, et al. AQP4 knockout impairs proliferation, migration and neuronal differentiation of adult neural stem cells. J Cell Sci 2008;121:4029-4036.
12. 2+ signaling events elicited by cerebral edema. Proc Natl Acad Sci U S A 2011;108:846-851.
13. Li X, Gao J, Ding J, et al. Aquaporin-4 expression contributes to decreases in brain water content during mouse postnatal development. Brain Res Bull 2013;94:49-55.
14. Zeng XN, Xie LL, Liang R, et al. AQP4 knockout aggravates ischemia/reperfusion injury in mice. CNS Neurosci Ther 2012;18:388-394.
15. Auguste KI, Jin S, Uchida K, et al. Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury. FASEB J 2007;21:108-116.
16. Scharfman HE, Binder DK. Aquaporin-4 water channels and synaptic plasticity in the hippocampus. Neurochem Int 2013;63:702-711.
17. Fan Y, Zhang J, Sun XL, et al. Sex- and region-specific alterations of basal amino acid and monoamine metabolism in the brain of aquaporin-4 knockout mice. J Neurosci Res 2005;82:458-464.
18. Shi WZ, Zhao CZ, Zhao B, et al. Aggravated inflammation and increased expression of cysteinyl leukotriene receptors in the brain after focal cerebral ischemia in AQP4-deficient mice. Neurosci Bull 2012;28:680-692.
19. Papadopoulos MC, Verkman AS. Aquaporin water channels in the nervous system. Nat Rev Neurosci 2013;14:265-277.
20. Kong H, Sha LL, Fan Y, et al. Requirement of AQP4 for antidepressive efficiency of fluoxetine: Implication in adult hippocampal neurogenesis. Neuropsychopharmacology 2009;34:1263-1276.
21. Zhao Y, Ma R, Shen J, et al. A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 2008;581:113-120.
22. Fan Y, Kong H, Shi X, et al. Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine and astrocytic modulation. Neurobiol Aging 2008;29:1226-1236.
23. Zeng XN, Sun XL, Gao L, et al. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci 2007;34:34-39.
24. Sousa N, Almeida OF, Holsboer F, et al. Maintenance of hippocampal cell numbers in young and aged rats submitted to chronic unpredictable stress. Comparison with the effects of corticosterone treatment. Stress 1998;2:237-249.
25. Sun JD, Liu Y, Yuan YH, et al. Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 2012;37:1305-1320.
26. Yang J, Li MX, Luo Y, et al. Chronic ceftriaxone treatment rescues hippocampal memory deficit in AQP4 knockout mice via activation of GLT-1. Neuropharmacology 2013;75C:213-222.
27. Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol Psychiatry 2010;67:1048-1056.
28. MacQueen G, Frodl T. The hippocampus in major depression: Evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry 2011;16:252-264.
29. Krishnan V, Nestler EJ. Animal models of depression: Molecular perspectives. Curr Top Behav Neurosci 2011;7:121-147.
30. David DJ, Samuels BA, Rainer Q, et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009;62:479-493.
31. Ago Y, Yano K, Araki R, et al. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice. Neuropharmacology 2013;65:29-38.
32. Berton O, Hahn CG, Thase ME. Are we getting closer to valid translational models for major depression? Science 2012;338:75-79.
33. Tynan RJ, Beynon SB, Hinwood M, et al. Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. Acta Neuropathol 2013;126:75-91.
34. Gosselin RD, Gibney S, O'Malley D, et al. Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 2009;159:915-925.
35. Chandley MJ, Szebeni K, Szebeni A, et al. Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. J Psychiatry Neurosci 2013;38:276-284.
36. Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA. Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology 2010;58:465-473.
37. John CS, Smith KL, Van't Veer A, et al. Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia. Neuropsychopharmacology 2012;37:2467-2475.
38. Yan HT, Wu N, Lu XQ, et al. Aquaporin-4 deficiency attenuates opioid dependence through suppressing glutamate transporter-1 down-regulation and maintaining glutamate homeostasis. CNS Neurosci Ther 2013;19:12-19.
39. Hinson SR, Roemer SF, Lucchinetti CF, et al. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008;205:2473-2481.
40. Mitterauer BJ. Downregulation and upregulation of glial connexins may cause synaptic imbalances responsible for the pathophysiology of bipolar disorder. CNS Neurosci Ther 2011;17:281-293.
41. Allen SJ, Watson JJ, Shoemark DK, et al. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 2013;138:155-175.
42. Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 2012;64:238-258.
43. Masi G, Brovedani P. The hippocampus, neurotrophic factors and depression: Possible implications for the pharmacotherapy of depression. CNS Drugs 2011;25:913-931.
44. Uchida S, Hara K, Kobayashi A, et al. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 2011;69:359-372.
45. Micheva KD, Busse B, Weiler NC, et al. Single-synapse analysis of a diverse synapse population: Proteomic imaging methods and markers. Neuron 2010;68:639-653.
46. Chua JJ, Kindler S, Boyken J, Jahn R. The architecture of an excitatory synapse. J Cell Sci 2010;123:819-823.
47. Liu HH, Payne HR, Wang B, Brady ST. Gender differences in response of hippocampus to chronic glucocorticoid stress: Role of glutamate receptors. J Neurosci Res 2006;83:775-786.
48. Khurana RC, Devaud LL. Sex differences in neurotransmission parameters in response to repeated mild restraint stress exposures in intact male, female and ovariectomised female rats. J Neuroendocrinol 2007;19:511-520.
49. Doucet MV, Harkin A, Dev KK. The PSD-95/nNOS complex: New drugs for depression? Pharmacol Ther 2012;133:218-229.
50. Dagyte G, Luiten PG, De Jager T, et al. Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain. J Neurosci Res 2011;89:1646-1657.
51. Bessa JM, Ferreira D, Melo I, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009;14:764-773, 739.
52. Silva R, Mesquita AR, Bessa J, et al. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: The role of glycogen-synthase-kinase-3beta. Neuroscience 2008;152:656-669.
53. Koelsch A, Feng Y, Fink DJ, Mata M. Transgene-mediated GDNF expression enhances synaptic connectivity and GABA transmission to improve functional outcome after spinal cord contusion. J Neurochem 2010;113:143-152.
54. Lussier AL, Lebedeva K, Fenton EY, et al. The progressive development of depression-like behavior in corticosterone-treated rats is paralleled by slowed granule cell maturation and decreased reelin expression in the adult dentate gyrus. Neuropharmacology 2013;71:174-183.
55. Snyder JS, Soumier A, Brewer M, et al. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011;476:458-461.
56. Basco D, Nicchia GP, D'Alessandro A, et al. Absence of aquaporin-4 in skeletal muscle alters proteins involved in bioenergetic pathways and calcium handling. PLoS One 2011;6:e19225.
57. Cheng YS, Tang YQ, Dai DZ, Dai Y. AQP4 knockout mice manifest abnormal expressions of calcium handling proteins possibly due to exacerbating pro-inflammatory factors in the heart. Biochem Pharmacol 2012;83:97-105.
58. Yu IT, Lee SH, Lee YS, Son H. Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitro. Biochem Biophys Res Commun 2004;317:484-490.
59. Jauregui-Huerta F, Ruvalcaba-Delgadillo Y, Gonzalez-Castaneda R, et al. Responses of glial cells to stress and glucocorticoids. Curr Immunol Rev 2010;6:195-204.